Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts

Benzinga14:45 ET

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

Analyst Upgrades14:29 ET

European Equities Traded in the US as American Depositary Rise in Wednesday Trading

MT Newswires11:12 ET

Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana

Benzinga11:08 ET

Sanofi (SNY.US) successfully introduced the TL1A monoclonal antibody for the treatment of inflammatory bowel disease in a Phase IIb study with an investment of 1.5 billion dollars.

In October 2023, Sanofi (SNY.US) reached an agreement with Teva for the development and commercialization of the drug, with an upfront payment of 0.5 billion dollars and milestone payments of up to 1 billion dollars.

Zhitong FinanceDec 18 08:18 ET

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Zacks Dec 18 07:30 ET